Commentary 10.1172/JCI128745
Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, Massachusetts, USA.
Address correspondence to: Mary Elizabeth Patti, 1 Joslin Place, Room 620, Boston, Massachusetts 02215, USA. Phone: 617.309.2635; Email: mary.elizabeth.patti@joslin.harvard.edu.
Find articles by
Osataphan, S.
in:
JCI
|
PubMed
|
Google Scholar
|
Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, Massachusetts, USA.
Address correspondence to: Mary Elizabeth Patti, 1 Joslin Place, Room 620, Boston, Massachusetts 02215, USA. Phone: 617.309.2635; Email: mary.elizabeth.patti@joslin.harvard.edu.
Find articles by
Patti, M.
in:
JCI
|
PubMed
|
Google Scholar
|
First published May 6, 2019 - More info
Vertical sleeve gastrectomy (VSG) is an effective therapeutic approach for obesity and type 2 diabetes but is associated with osteoporosis. In this issue of the JCI, Li et al. report that VSG rapidly reduces bone mass, as observed in humans, via rapid demineralization and decreased bone formation, independent of weight loss or Ca2+/vitamin D deficiency. VSG also reduces bone marrow adipose tissue, in part via increased granulocyte–colony stimulating factor (G-CSF). The interplay between VSG-mediated effects on systemic metabolism and bone biology remain to be investigated. These findings suggest novel mechanisms and therapeutic targets for bariatric surgery–induced osteoporosis.
A subscription is required for you to read this article in full. If you are a subscriber, you may sign in to continue reading.
Click here to sign into your account.
Please select one of the subscription options, which includes a low-cost option just for this article.
If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).
Please try these troubleshooting tips.